Azenta Life Sciences
Violetta Hughes is an accomplished finance leader with extensive experience in accounting and external reporting. Currently serving as Vice President and Chief Accounting Officer at Azenta Life Sciences since January 2023, Violetta oversees all accounting functions, including audits, SEC reporting, and compliance with SOX and US GAAP, presenting complex matters to the Audit Committee. Prior roles include Vice President Finance and Chief Accounting Officer at Akebia Therapeutics, and Senior Vice President of Accounting and Corporate Controller at AMAG Pharmaceuticals, where responsibilities encompassed comprehensive accounting oversight and management of extensive teams. Violetta's earlier positions also include significant roles at Hologic, Inc., Amicore, Oak Technology, and MKS Instruments, showcasing a career built on strong financial expertise and transformational project leadership. Violetta holds a Bachelor of Science in Accounting from the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices
Azenta Life Sciences
3 followers
Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.